BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32963266)

  • 1. Local anaesthesia decreases nerve growth factor induced masseter hyperalgesia.
    Costa YM; Exposto FG; Castrillon EE; Conti PCR; Bonjardim LR; Svensson P
    Sci Rep; 2020 Sep; 10(1):15458. PubMed ID: 32963266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Injection of nerve growth factor into human masseter muscle evokes long-lasting mechanical allodynia and hyperalgesia.
    Svensson P; Cairns BE; Wang K; Arendt-Nielsen L
    Pain; 2003 Jul; 104(1-2):241-7. PubMed ID: 12855334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of NGF-induced muscle sensitization on proprioception and nociception.
    Svensson P; Wang K; Arendt-Nielsen L; Cairns BE
    Exp Brain Res; 2008 Jul; 189(1):1-10. PubMed ID: 18478213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nerve growth factor-evoked masseter muscle sensitization and perturbation of jaw motor function in healthy women.
    Svensson P; Castrillon E; Cairns BE
    J Orofac Pain; 2008; 22(4):340-8. PubMed ID: 19090407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Masseter corticomotor excitability is decreased after intramuscular administration of nerve growth factor.
    Costa YM; Exposto FG; Kothari M; Castrillon EE; Conti PCR; Bonjardim LR; Svensson P
    Eur J Pain; 2019 Oct; 23(9):1619-1630. PubMed ID: 31192515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NGF-induced mechanical sensitization of the masseter muscle is mediated through peripheral NMDA receptors.
    Wong H; Kang I; Dong XD; Christidis N; Ernberg M; Svensson P; Cairns BE
    Neuroscience; 2014 Jun; 269():232-44. PubMed ID: 24704516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of lidocaine on nerve growth factor (NGF)-evoked heat- and mechanical hyperalgesia in humans.
    Weinkauf B; Obreja O; Schmelz M; Rukwied R
    Eur J Pain; 2012 Apr; 16(4):543-9. PubMed ID: 22396083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of low-dose intramuscular ketorolac on experimental pain in the masseter muscle of healthy women.
    Bendixen KH; Baad-Hansen L; Cairns BE; Svensson P
    J Orofac Pain; 2010; 24(4):398-407. PubMed ID: 21197512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of intramuscular nerve growth factor injection on the response properties of rat masseter muscle afferent fibers.
    Mann MK; Dong XD; Svensson P; Cairns BE
    J Orofac Pain; 2006; 20(4):325-36. PubMed ID: 17190031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial and temporal aspects of muscle hyperalgesia induced by nerve growth factor in humans.
    Andersen H; Arendt-Nielsen L; Svensson P; Danneskiold-Samsøe B; Graven-Nielsen T
    Exp Brain Res; 2008 Nov; 191(3):371-82. PubMed ID: 18813917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nerve growth factor experimentally-induced craniofacial muscle sensitization on referred pain frequency and number of headache days: A double-blind, randomized placebo-controlled study.
    Exposto FG; Masuda M; Castrillon EE; Svensson P
    Cephalalgia; 2018 Dec; 38(14):2006-2016. PubMed ID: 29528692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of propranolol and granisetron on experimentally induced pain and allodynia/hyperalgesia by intramuscular injection of serotonin into the human masseter muscle.
    Ernberg M; Lundeberg T; Kopp S
    Pain; 2000 Feb; 84(2-3):339-46. PubMed ID: 10666539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeated intramuscular injections of nerve growth factor induced progressive muscle hyperalgesia, facilitated temporal summation, and expanded pain areas.
    Hayashi K; Shiozawa S; Ozaki N; Mizumura K; Graven-Nielsen T
    Pain; 2013 Nov; 154(11):2344-2352. PubMed ID: 23867729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between Collagen and Lidocaine Intramuscular Injections in Terms of Their Efficiency in Decreasing Myofascial Pain within Masseter Muscles: A Randomized, Single-Blind Controlled Trial.
    Nitecka-Buchta A; Walczynska-Dragon K; Batko-Kapustecka J; Wieckiewicz M
    Pain Res Manag; 2018; 2018():8261090. PubMed ID: 29973970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on muscle pain by intramuscular injection of granisetron in patients with fibromyalgia.
    Ernberg M; Lundeberg T; Kopp S
    Pain; 2003 Feb; 101(3):275-282. PubMed ID: 12583870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nerve growth factor-induced muscle hyperalgesia facilitates ischaemic contraction-evoked pain.
    Sørensen LB; Gazerani P; Graven-Nielsen T
    Eur J Pain; 2019 Nov; 23(10):1814-1825. PubMed ID: 31314952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analgesic and anti-hyperalgesic effects of muscle injections with lidocaine or saline in patients with fibromyalgia syndrome.
    Staud R; Weyl EE; Bartley E; Price DD; Robinson ME
    Eur J Pain; 2014 Jul; 18(6):803-12. PubMed ID: 24193993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve growth factor alters the sensitivity of rat masseter muscle mechanoreceptors to NMDA receptor activation.
    Wong H; Dong XD; Cairns BE
    J Neurophysiol; 2014 Nov; 112(9):2275-82. PubMed ID: 25122708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intramuscular morphine in men and women with temporomandibular disorder with myofascial pain.
    Kang SK; Lee YH; Park H; Ro JY; Auh QS
    Oral Dis; 2018 Nov; 24(8):1591-1598. PubMed ID: 29920852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of hypertonic saline-induced masseter muscle pain characteristics, by an infusion of the serotonin receptor type 3 antagonist granisetron.
    Christidis N; Ioannidou K; Milosevic M; Segerdahl M; Ernberg M
    J Pain; 2008 Oct; 9(10):892-901. PubMed ID: 18585094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.